4//SEC Filing
TAYLOR GLEN A 4
Accession 0001062993-25-015411
CIK 0001840877other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:17 PM ET
Size
40.2 KB
Accession
0001062993-25-015411
Insider Transaction Report
Form 4
TAYLOR GLEN A
Director10% Owner
Transactions
- Award
Warrant (right to buy)
2025-09-04+750,000→ 750,000 total(indirect: By LLC)Exercise: $1.35Exp: 2028-12-31→ Class A Common Stock (750,000 underlying) - Award
Warrant (right to buy)
2025-09-04+250,000→ 250,000 total(indirect: By LLC)Exercise: $3.04Exp: 2028-12-31→ Class A Common Stock (250,000 underlying) - Disposition to Issuer
Warrant (right to buy)
2025-09-04−250,000→ 0 total(indirect: By LLC)Exercise: $3.04Exp: 2026-02-27→ Class A Common Stock (250,000 underlying) - Disposition to Issuer
Warrant (right to buy)
2025-09-04−500,000→ 0 total(indirect: By LLC)Exercise: $1.24Exp: 2026-02-27→ Class A Common Stock (500,000 underlying) - Award
Warrant (right to buy)
2025-09-04+500,000→ 500,000 total(indirect: By LLC)Exercise: $1.24Exp: 2028-12-31→ Class A Common Stock (500,000 underlying) - Disposition to Issuer
Warrant (right to buy)
2025-09-04−750,000→ 0 total(indirect: By LLC)Exercise: $1.35Exp: 2028-03-11→ Class A Common Stock (750,000 underlying)
Holdings
- 2,953,607
Class A Common Stock
- 1,000,000(indirect: By LLC)
Series A Preferred Stock
Exercise: $11.50→ Class A Common Stock (869,565 underlying) - 2,526,058(indirect: By Taylor Sports Group)
Class A Common Stock
- 4,810,384(indirect: By LLC)
Class A Common Stock
Footnotes (11)
- [F1]The Reporting Person is the owner and chairman of Taylor Sports Group.
- [F10]The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable.
- [F11]The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable.
- [F2]GAT Funding, LLC is an entity controlled by the Reporting Person.
- [F3]Fully exercisable and there is no expiration date.
- [F4]The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable.
- [F5]Fully exercisable.
- [F6]The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable.
- [F7]The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable.
- [F8]The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable.
- [F9]The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable.
Issuer
Envoy Medical, Inc.
CIK 0001840877
Entity typeother
Related Parties
1- filerCIK 0001213971
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 5:17 PM ET
- Size
- 40.2 KB